Benefits
Oxygen transport
Iron is part of hemoglobin, which carries oxygen in red blood cells, and of myoglobin, which supplies oxygen to muscle. Most of the 3 to 4 grams of iron in an adult's body is in hemoglobin.
Less fatigue when iron stores are low
In 198 menstruating women with fatigue, ferritin below 50 ug/L and no anemia, 80 mg of iron a day for 12 weeks cut fatigue scores by 47.7 percent against 28.8 percent on placebo. A meta-analysis of 4 trials in non-anemic, iron-deficient adults also found less self-reported fatigue.
Exercise performance in menstruating women
A Cochrane review of trials in menstruating women found daily iron improved maximal and submaximal exercise performance and appeared to reduce fatigue. In non-anemic, iron-deficient adults, though, a meta-analysis of 9 trials found no change in VO2max or timed exercise tests.
Attention and brain development
Iron deficiency in infancy is linked with poorer thinking, motor and social skills that persist into adolescence. In a meta-analysis of 14 trials in children over 6, teens and women, iron improved attention and concentration and raised IQ by 2.5 points only in those with anemia; the trials were small and short.
Iron needs in pregnancy
In a Cochrane review of pregnancy trials, daily iron reduced anemia at term by 70 percent and iron deficiency at term by 57 percent, based on low-quality evidence. Effects on birth weight and preterm birth were not clear.
Mechanism of action
Hemoglobin and myoglobin formation
Iron binds to protoporphyrin IX to form heme, which is incorporated into globin proteins to create hemoglobin and myoglobin. Each hemoglobin molecule contains four iron atoms.
Electron transport chain function
Iron-sulfur clusters and heme groups in Complexes I, II, III, and IV of the mitochondrial electron transport chain shuttle electrons during oxidative phosphorylation, producing the majority of cellular ATP.
Neurotransmitter synthesis
Iron is a cofactor for tyrosine hydroxylase (dopamine synthesis) and tryptophan hydroxylase (serotonin synthesis). In animal research, iron deficiency early in life alters brain neurotransmitter function.
Clinical trials
Multicentre, closed-label, observer-blinded, placebo-controlled randomized trial of ferrous sulfate (80 mg elemental iron a day) for 12 weeks. (Vaucher et al. 2012, CMAJ)
198 menstruating women aged 18 to 53 in France with fatigue, ferritin below 50 ug/L and hemoglobin above 12.0 g/dL.
Fatigue scores fell 47.7 percent on iron against 28.8 percent on placebo (p = 0.02), with no effect on quality of life, depression or anxiety. Hemoglobin rose 0.32 g/dL and ferritin 11.4 ug/L more than on placebo.
Cochrane systematic review of 67 randomized and quasi-randomized trials of daily oral iron. (Low et al. 2016, Cochrane Database of Systematic Reviews)
8506 menstruating women.
Iron lowered the risk of anemia (RR 0.39) and iron deficiency (RR 0.62), raised hemoglobin, improved maximal and submaximal exercise performance and appeared to reduce fatigue. Constipation and loose stools were about twice as common. Evidence on cognition was uncertain.
Systematic review and meta-analysis of 18 randomized trials of oral, intramuscular or intravenous iron. (Houston et al. 2018, BMJ Open)
1170 non-anemic, iron-deficient adults.
Iron reduced self-reported fatigue (SMD -0.38; 4 trials, 714 people) but did not change VO2max (9 trials, 235 people) or timed exercise tests. Hemoglobin and ferritin rose.
Systematic review and meta-analysis of 14 randomized trials of oral iron. (Falkingham et al. 2010, Nutrition Journal)
Children aged 6 and over, adolescents and women; no trials in men or older adults.
Iron improved attention and concentration regardless of starting iron status (SMD 0.59). IQ rose 2.5 points in anemic groups only, with no effect on memory, psychomotor skills or school achievement. The trials were generally small, short and methodologically weak.